pharmacy

Health care stocks for the most part traded notably lower Tuesday in reaction to the formation of a new not-for-profit company spearheaded by Amazon.com, Inc. (NASDAQ: AMZN)'s Jeff Bezos, JPMorgan Chase & Co. (NYSE: JPM)'s Jamie Dimon and Berkshire Hathaway Inc. (NYSE: BRK.A) (...

Is Amazon.com, Inc. (NASDAQ: AMZN) looking to enter the pharmacy space? A review of statewide pharmacy licenses answers the pressing question, according to Cowen.  The Analyst Cowen's Charles Rhyee does not directly cover Amazon's stock. The firm has an Outperform rating...

After 2017 ended less eventfully than many expected for the health care industry, investors are now turning their attention to the business trends impacting the industry in the new year. In a new note, Bernstein analyst Lance Wilkes describes what he views as the three most important sector...

CVS Health Corp (NYSE: CVS)'s proposed acquisition of Aetna Inc (NYSE: AET) is reason enough for at least one Wall Street analyst to turn bullish. The Analyst Morgan Stanley's Ricky Goldwasser upgraded CVS' stock from Equal-weight to Overweight with a price target boosted from $...

For more than two years, pharmaceutical giant Walgreens Boots Alliance Inc (NASDAQ: WBA) has been "tap dancing horizontally" with smaller rival Rite Aid Corporation (NYSE: RAD). In the end, Rite Aid agreed to sell Walgreens 1,932 of its stores in a $4.4-billion deal that now frees up...

CVS Health Corp (NYSE: CVS) and Aetna Inc (NYSE: AET) agreed to merge over the weekend, and some of Wall Street's top analysts released their initial take on the deal. The Analyst Baird's Eric Coldwell maintains a Neutral rating on CVS' stock with an unchanged $77 price target...

Many pharmacy investors are concerned that Amazon.com, Inc. (NASDAQ: AMZN) could soon enter the pharmacy space by partnering with or acquiring a pharmacy benefit manager. But these concerns may be overblown, at least according to one analyst. The Analyst Cowen's John Blackledge. The...

Shares of Thermo Fisher Scientific Inc. (NYSE: TMO) came under heavy selling pressure last Friday, which continued into Monday's trading session amid ongoing concerns that Amazon.com, Inc. (NASDAQ: AMZN) is looking to enter lab supplies and other health care related businesses. But Thermo Fisher's...

The bullish case for owning Walgreens Boots Alliance Inc (NASDAQ: WBA) has come to an end, says analysts at Morgan Stanley. The firm's Ricky Goldwasser downgrades Walgreens Boots' stock rating from Overweight to Equal-Weight with a price target lowered from $95 to $85. Walgreens is expected to...

Amazon.com, Inc. (NASDAQ: AMZN) is expected to take a big step into pharmacy ━ because it can. “We think that Amazon will enter the retail pharmacy industry, in large part because this is a large and disruptable market,” Bernstein analyst Lance Wilkes said in a Thursday note. But its...

2017 continues to be a challenge for Rite Aid Corporation (NYSE: RAD) from a fundamental point of view, especially at the pharmacy retail segment, Loop Capital Markets' Andrew Wolf commented in an initiation note. Although the company is now positioned for a turnaround in the second quarter now is...

Walgreens Boots Alliance Inc (NASDAQ: WBA) proposed back in 2015 to fully acquire Rite Aid Corporation (NYSE: RAD) in a deal that would value the smaller pharmacy retail chain at $9 per share. But regulatory concerns are part of the reason why the merger agreement is officially off the table....

Walgreens Boots Alliance Inc (NASDAQ: WBA)'s proposed acquisition of smaller rival Rite Aid Corporation (NYSE: RAD) was unlikely to receive regulatory approval unless it were to divest hundreds of stores to ease competitive concerns. Fred's, Inc. (NASDAQ: FRED), a relatively small pharmacy...

Shares of Rite Aid Corporation (NYSE: RAD) lost nearly 20 percent Thursday morning after the retail drugstore chain confirmed a finalized asset purchase agreement with rival Walgreens Boots Alliance Inc (NASDAQ: WBA). Walgreens has attempted to acquire the entirety of Rite Aid since 2015, but...

Shares of Walgreens Boots Alliance Inc (NASDAQ: WBA) were trading lower by more than 3 percent Wednesday after the company reported its third quarter results and updated its full year fiscal 2016 expectations. Walgreens said it earned $1.18 per share in the third quarter on revenue of $29.5...